1. Home
  2. QTTB
  3. QTTB News

Latest Q32 Bio Inc. Common Stock (QTTB) News on July 27, 2024

Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis

PR Newswire

18 days ago

Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis

Share on Social Networks: